Zacks Investment Research on MSN
Hologic Q1 earnings preview: How should you play the stock now?
Hologic HOLX is set to release first-quarter fiscal 2026 results on Jan. 29, after the closing bell. The Zacks Consensus ...
HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...
Zacks Investment Research on MSN
Hologic (HOLX) earnings expected to grow: What to know ahead of next week's release
Wall Street expects a year-over-year increase in earnings on higher revenues when Hologic (HOLX) reports results for the ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...
January is observed as Cervical Cancer Awareness Month, and HologicHOLX has long been a leader in cervical cancer screening.
Hologic has drafted professional basketball player Erica Wheeler to raise awareness of cervical cancer screening, putting the ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today launched Project Health Equality (PHE), a unique initiative that strives to address the ...
Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.
After spending much of 2021 growing its footprint beyond the U.S. by acquiring a handful of diagnostic developers scattered across Europe and expanding its women’s health-focused offerings throughout ...
After reaping a windfall from COVID-19 diagnostic demand, Hologic’s spending spree continues with its largest acquisition yet: It’s claimed Mobidiag, the Finnish-French molecular test maker, with a ...
Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results